Elixirr International PLC Purchase of Shares by Employee Benefit Trust (9391B)
06 October 2022 - 5:00PM
UK Regulatory
TIDMELIX
RNS Number : 9391B
Elixirr International PLC
06 October 2022
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Purchase of Shares by Employee Benefit Trust
Elixirr International plc (AIM:ELIX), an established, global
award-winning challenger consultancy, announces that on 5 October
2022 the Elixirr International plc Employee Benefit Trust (the
"EBT") purchased in the market (the "Purchase") 166,666 ordinary
shares in the capital of the Company ("Ordinary Shares") at an
average price of 600 pence per Ordinary Share.
The Purchase has been made at the instruction of Sanne Fiduciary
Services Limited as trustee of the EBT following a recommendation
by the Board of the Company. The decision to make the Purchase
reflects the view that the current market price per Ordinary Share
does not reflect the underlying value of the Elixirr Group in light
of the Company's strong interim results as announced on 20
September 2022 and its continued prospects.
As set out in the Company's Admission Document, Ordinary Shares
held by the EBT are held for the benefit of employees of the Group
including to satisfy awards under the Company's employee incentive
schemes. Shares held by the EBT can also be sold to persons who
become employees of the Elixirr Group in connection with an
acquisition. Accordingly, the Purchase will mitigate the need for
dilution in the equity of the Company as it executes on its growth
strategy.
For further information, please contact:
Elixirr International plc
Stephen Newton, CEO
Graham Busby, CFO
investor-relations@elixirr.com
Public and Investor Relations contacts:
Caroline Pitt
finnCap Ltd (Nominated Adviser & Sole Broker)
Christopher Raggett, Charlie Beeson (Corporate
Finance)
Alice Lane, Sunila De Silva (ECM) +44 (0)20 7220 0500
About Elixirr International plc
Elixirr is an established global award-winning management
consultancy, challenging the larger consultancies by delivering
innovative and bespoke solutions to a repeat, globally-recognised
client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby,
Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business
advisors who identified a market opportunity to provide bespoke,
personal services as a 'challenger' to the traditional consultancy
businesses in the market. Elixirr guides its clients to overcome
challenges such as: future-proofing against technological
disruption; development and roll-out of new propositions, products
and services; incubating new businesses; navigating a more complex
and multinational regulatory environment; and project management
and implementation of major change programmes.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUVANRUNURRAA
(END) Dow Jones Newswires
October 06, 2022 02:00 ET (06:00 GMT)
Elixirr (LSE:ELIX)
Historical Stock Chart
From Apr 2024 to May 2024
Elixirr (LSE:ELIX)
Historical Stock Chart
From May 2023 to May 2024